This session explores new therapeutics with in-clinic data.
FEATURED COMPANIES
Achelios Therapeutics, Crist J Frangakis
Aerami Therapeutics, John Patton
Amalgent Therapeutics, Malcolm A Meyn
Avior Bio, NIRAJ VASISHT
Enfuego Therapeutics, Chad Pecot
Opus Genetics, Ben Yerxa
Plakous Therapeutics, Scott Washburn
Praetego, Pepper Landson
Ten63 Therapeutics, Marcel Frenkel